Document is current
Any future updates will be listed below
-
Authors
Class, Jonathan A.
Vishnubhotla, Ramana V.
Haas, David M.
Hull, Ilana W.
Sadhasivam, Senthilkumar
Radhakrishnan, Rupa
-
Funding
Funding for this research was provided by:
National Institutes of Health, United States (R01HD096800)
National Institutes of Health, United States (R01DA059321)
- License Information
-
More Information
Article History
Received: 28 August 2025
Accepted: 4 November 2025
First Online: 15 December 2025
Declarations
:
: Dr. Sadhasivam received pay from UpToDate: Anesthesia for Tonsillectomy and Neuroptics, Inc for studying opioid-induced respiratory depression in pediatric tonsillectomy. Dr. Sadhasivam is one of the inventors in the approved U.S. patents focused on opioid pharmacogenetics: U.S. Patent No. 9944985, 10662476, 16/850537, 16/946401, 16/946399, 10878939 and has not received any royalty so far. Dr. Sadhasivam is the founder and chief medical officer of OpalGenix, Inc with equity interest. Dr. Sadhasivam is the chief medical officer of NCAP Medical, LLC with equity interest. There is no financial conflict with the current article.
